India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What effects do women experience after menopause? Bone density can decrease by 10-20 percent in the first 5-7 years after menopause . This increases the risk of back pain and fractures in minor injuries. What effects do women experience after menopause? During perimenopause , estrogen levels decrease and menstruation becomes irregular, which causes various physical and mental symptoms. When the ovaries' ability to produce eggs decreases and menstruation begins to become irregular, the stage before menopause (perimenopause) begins. During this period, estrogen hormone levels begin to decline and various symptoms appear. There are also racial and cultural differences in this process. According to the US 'Study of Women's Health Across the Nation', African-American (black) women experience early and premature perimenopause at a higher rate than white women. They have been found to experience vasomotor symptoms – hot flashes , longer-lasting (up to 10 years) and more pai...